challenge: What was Ortho-McNeil Pharmaceutical charged with in 2010 regarding its epilepsy drug Topamax?
  
  A. Illegally promoting Topamax for unapproved uses
  B. Mislabeling Topamax as a treatment for diabetes
  C. Failing to disclose side effects to the FDA
  D. Not conducting adequate clinical trials for Topamax
  Answer: 